XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
Revenues
3 Months Ended
Mar. 31, 2022
Revenues  
Revenues

Note 2 - Revenues

Nature of Products and Services

The following tables present our revenues by primary product and service offering (in thousands):

Three Months Ended March 31, 2022

Three Months Ended March 31, 2021

    

    

Software and

    

    

    

Software and

    

TASER

Sensors

Total

TASER

Sensors

Total

TASER 7

$

50,066

$

$

50,066

$

33,991

$

$

33,991

TASER X26P

 

9,479

 

 

9,479

 

9,963

 

 

9,963

TASER X2

 

3,619

 

 

3,619

 

12,778

 

 

12,778

TASER Consumer devices

 

1,696

 

 

1,696

 

2,205

 

 

2,205

Cartridges

 

37,825

 

 

37,825

 

30,418

 

 

30,418

Axon Body

 

 

29,708

 

29,708

 

 

19,756

 

19,756

Axon Flex

 

 

1,329

 

1,329

 

 

905

 

905

Axon Fleet

 

 

13,820

 

13,820

 

 

3,763

 

3,763

Axon Dock

 

 

7,480

 

7,480

 

 

6,920

 

6,920

Axon Evidence and cloud services

 

3,017

 

79,939

 

82,956

 

1,396

 

52,294

 

53,690

Extended warranties

 

6,679

 

9,061

 

15,740

 

5,646

 

7,500

 

13,146

Other

 

1,979

 

729

 

2,708

 

2,602

 

4,882

 

7,484

Total

$

114,360

$

142,066

$

256,426

$

98,999

$

96,020

$

195,019

The following table presents our revenues disaggregated by geography (in thousands):

Three Months Ended March 31, 

2022

2021

United States

    

$

214,214

    

84

%  

$

160,386

    

82

%  

Other countries

 

42,212

 

16

 

34,633

 

18

Total

$

256,426

 

100

%  

$

195,019

 

100

%  

Contract Balances

The following table presents our contract assets, contract liabilities and certain information related to these balances as of and for the three months ended March 31, 2022 (in thousands):

    

March 31, 2022

Contract assets, net

$

177,477

Contract liabilities (deferred revenue)

 

467,565

Revenue recognized in the period from:

 

  

Amounts included in contract liabilities at the beginning of the period

 

104,043

Contract liabilities (deferred revenue) consisted of the following (in thousands):

March 31, 2022

December 31, 2021

    

Current

    

Long-Term

    

Total

    

Current

    

Long-Term

    

Total

Warranty:

 

  

 

  

 

  

 

  

 

  

 

  

TASER

$

27,476

$

1,401

$

28,877

$

21,257

$

4,766

$

26,023

Software and Sensors

 

21,736

 

15,621

 

37,357

 

23,175

 

18,137

 

41,312

 

49,212

 

17,022

 

66,234

 

44,432

 

22,903

 

67,335

Hardware:

 

  

 

  

 

  

 

  

 

  

 

  

TASER

 

38,828

 

3,618

 

42,446

 

12,944

 

28,727

 

41,671

Software and Sensors

 

50,151

 

71,408

 

121,559

 

34,862

 

81,223

 

116,085

 

88,979

 

75,026

 

164,005

 

47,806

 

109,950

 

157,756

Services:

 

  

 

  

 

  

 

  

 

  

 

  

TASER

 

4,309

 

2,066

 

6,375

 

2,701

 

3,482

 

6,183

Software and Sensors

 

184,127

 

46,824

 

230,951

 

170,652

 

49,386

 

220,038

188,436

48,890

237,326

173,353

52,868

226,221

Total

$

326,627

$

140,938

$

467,565

$

265,591

$

185,721

$

451,312

March 31, 2022

December 31, 2021

    

Current

    

Long-Term

    

Total

    

Current

    

Long-Term

    

Total

TASER

$

70,613

$

7,085

$

77,698

$

36,902

$

36,975

$

73,877

Software and Sensors

 

256,014

 

133,853

 

389,867

 

228,689

 

148,746

 

377,435

Total

$

326,627

$

140,938

$

467,565

$

265,591

$

185,721

$

451,312

Remaining Performance Obligations

As of March 31, 2022, we had approximately $2.97 billion of remaining performance obligations, which included both recognized contract liabilities as well as amounts that will be invoiced and recognized in future periods. The remaining performance obligations are limited only to arrangements that meet the definition of a contract under Topic 606 as of March 31, 2022. We expect to recognize between 15% - 20% of this balance over the next twelve months, and generally expect the remainder to be recognized over the following five to seven years, subject to risks related to delayed deployments, budget appropriation or other contract cancellation clauses.